CINC Corp. (4378) AI Stock Analysis

• Market Cap: ¥1.48B
• Dividend Yield: N/A
• Average Volume (3M): 3.24K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.04
• Revenue Growth: -3.24%
• EPS Growth: -298.72%
• Country: JP
• Employees: 118
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Infrastructure
• EPS (TTM): -20.08
• Shares Outstanding: 3,432,865
• 10 Day Avg. Volume: 4,280
• 30 Day Avg. Volume: 3,236
• PEG Ratio: 0.05
• Price to Book (P/B): 1.58
• Price to Sales (P/S): 1.20
• P/FCF Ratio: 14.78
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 58 Neutral
• Price Target: ¥537.00 ▲(5.29% Upside)

CINC Corp.'s overall stock score is primarily supported by its strong financial performance, characterized by revenue growth and a solid balance sheet. However, the bearish technical indicators and negative valuation metrics significantly weigh down the score, indicating potential risks in the short term.

CINC Corp. Business Overview & Revenue Model

Company Description

CINC Corp. (4378) is a technology-driven company specializing in the development and provision of innovative software solutions and services for the healthcare sector. Operating primarily within the health tech industry, CINC Corp. focuses on enhancing patient care and streamlining healthcare operations through its core products, which include electronic health record (EHR) systems, patient engagement platforms, and data analytics tools. The company aims to leverage technology to improve healthcare outcomes and efficiency for providers and patients alike.

How the Company Makes Money

CINC Corp. generates revenue primarily through the sale of its software solutions and subscription-based services. The key revenue streams include licensing fees from its EHR systems, subscription fees from its patient engagement platforms, and consulting services related to the implementation and optimization of its software. Additionally, CINC Corp. may engage in partnerships with healthcare providers and institutions to offer customized solutions, which can further enhance its earnings. The company's focus on data analytics also opens avenues for monetizing insights derived from healthcare data, creating additional revenue opportunities.

CINC Corp. Financial Statement Overview

Summary

CINC Corp. demonstrates strong revenue growth and a robust balance sheet with low leverage and high equity levels. While profitability margins have faced pressure, improvements in net income and cash flow generation highlight effective cost control and cash management.

Income Statement

CINC Corp. has shown stable revenue growth over the years, with a significant increase in gross profit margin, indicating efficient cost management. However, the EBIT and EBITDA margins have declined recently compared to previous years, reflecting challenges in operational efficiency. Net profit margin has improved, suggesting better control over non-operational expenses.

Balance Sheet

The company maintains a strong equity position with a low debt-to-equity ratio, indicating financial stability and low leverage. The return on equity is improving, reflecting effective utilization of shareholder equity. The equity ratio is high, underscoring a solid financial foundation with a good buffer against liabilities.

Cash Flow

CINC Corp. has demonstrated a significant improvement in free cash flow, suggesting enhanced cash management and operational efficiency. The operating cash flow to net income ratio is strong, though historical fluctuations in cash flow indicate potential volatility in cash generation capabilities.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	951.69M	1.99B	1.95B	1.81B	1.31B	934.36M
Gross Profit	620.10M	1.32B	1.37B	1.31B	920.11M	638.04M
EBITDA	3.43M	119.01M	69.19M	337.87M	222.15M	39.15M
Net Income	-57.32M	51.92M	5.26M	201.39M	129.54M	11.43M
Balance Sheet
Total Assets	1.51B	1.91B	1.84B	2.03B	1.89B	767.27M
Cash, Cash Equivalents and Short-Term Investments	951.00M	1.35B	1.28B	1.52B	1.60B	529.11M
Total Debt	0.00	16.68M	71.61M	151.62M	244.44M	358.52M
Total Liabilities	357.09M	395.63M	358.62M	527.64M	594.58M	531.44M
Stockholders Equity	1.15B	1.51B	1.48B	1.50B	1.29B	235.83M
Cash Flow
Free Cash Flow	0.00	161.72M	-168.10M	113.05M	245.04M	3.52M
Operating Cash Flow	0.00	205.42M	-17.02M	185.50M	289.83M	34.98M
Investing Cash Flow	0.00	-56.42M	-127.91M	-174.81M	-26.13M	-73.30M
Financing Cash Flow	0.00	-74.26M	-100.87M	-91.06M	811.06M	105.28M

CINC Corp. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 510.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4378, the sentiment is Negative. The current price of 510 is below the 20-day moving average (MA) of 535.65, below the 50-day MA of 564.16, and below the 200-day MA of 580.88, indicating a bearish trend. The MACD of -14.69 indicates Positive momentum. The RSI at 30.62 is Neutral, neither overbought nor oversold. The STOCH value of 5.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4378.

CINC Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4374	76 Outperform	¥10.70B	24.36	―	0.50%	21.21%	82.61%
4493	76 Outperform	¥18.96B	34.83	―	0.16%	28.56%	-13.56%
3992	67 Neutral	¥20.92B	25.32	―	2.28%	2.06%	-16.53%
4178	64 Neutral	¥2.62B	38.88	―	―	-3.54%	-41.26%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
4488	60 Neutral	¥11.49B	-27.59	―	―	6.29%	-180.52%
4378	58 Neutral	¥1.48B	-12.50	―	―	-3.24%	-298.72%